These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

724 related items for PubMed ID: 20445344

  • 1. Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodes.
    Søndergaard H, Galsgaard ED, Bartholomaeussen M, Straten PT, Odum N, Skak K.
    J Immunother; 2010 Apr; 33(3):236-49. PubMed ID: 20445344
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
    Kumano M, Hara I, Furukawa J, Oniki S, Nagai H, Miyake H, Fujisawa M.
    J Urol; 2007 Oct; 178(4 Pt 1):1504-9. PubMed ID: 17707061
    [Abstract] [Full Text] [Related]

  • 3. Central role of tumor-associated CD8+ T effector/memory cells in restoring systemic antitumor immunity.
    Kilinc MO, Gu T, Harden JL, Virtuoso LP, Egilmez NK.
    J Immunol; 2009 Apr 01; 182(7):4217-25. PubMed ID: 19299720
    [Abstract] [Full Text] [Related]

  • 4. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity.
    Guo J, Wang B, Zhang M, Chen T, Yu Y, Regulier E, Homann HE, Qin Z, Ju DW, Cao X.
    Gene Ther; 2002 Jun 01; 9(12):793-803. PubMed ID: 12040461
    [Abstract] [Full Text] [Related]

  • 5. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
    Hwang KS, Cho WK, Yoo J, Seong YR, Kim BK, Kim S, Im DS.
    Cancer Gene Ther; 2004 Jun 01; 11(6):397-407. PubMed ID: 15044962
    [Abstract] [Full Text] [Related]

  • 6. Immunotherapy of established tumors in mice by intratumoral injection of interleukin-2 plasmid DNA: induction of CD8+ T-cell immunity.
    Saffran DC, Horton HM, Yankauckas MA, Anderson D, Barnhart KM, Abai AM, Hobart P, Manthorpe M, Norman JA, Parker SE.
    Cancer Gene Ther; 1998 Jun 01; 5(5):321-30. PubMed ID: 9824052
    [Abstract] [Full Text] [Related]

  • 7. Intratumoral delivery of IL-12 gene by polyvinyl polymeric vector system to murine renal and colon carcinoma results in potent antitumor immunity.
    Mendiratta SK, Quezada A, Matar M, Wang J, Hebel HL, Long S, Nordstrom JL, Pericle F.
    Gene Ther; 1999 May 01; 6(5):833-9. PubMed ID: 10505108
    [Abstract] [Full Text] [Related]

  • 8. Combination B7-Fc fusion protein treatment and Treg cell depletion therapy.
    Liu A, Hu P, Khawli LA, Epstein AL.
    Clin Cancer Res; 2005 Dec 01; 11(23):8492-502. PubMed ID: 16322313
    [Abstract] [Full Text] [Related]

  • 9. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes.
    Martinotti A, Stoppacciaro A, Vagliani M, Melani C, Spreafico F, Wysocka M, Parmiani G, Trinchieri G, Colombo MP.
    Eur J Immunol; 1995 Jan 01; 25(1):137-46. PubMed ID: 7843224
    [Abstract] [Full Text] [Related]

  • 10. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD, Ravaggi A, Bellone S, Pecorelli S, Cannon M, Parham GP, Hermonat PL.
    Gynecol Oncol; 2001 Jun 01; 81(3):424-32. PubMed ID: 11371133
    [Abstract] [Full Text] [Related]

  • 11. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
    Lee JM, Mahtabifard A, Yamada R, Crystal RG, Korst RJ.
    Clin Cancer Res; 2002 Nov 01; 8(11):3561-9. PubMed ID: 12429647
    [Abstract] [Full Text] [Related]

  • 12. Tumor-localized ligation of CD3 and CD28 with systemic regulatory T-cell depletion induces potent innate and adaptive antitumor responses.
    Lee CH, Chiang YH, Chang SE, Chong CL, Cheng BM, Roffler SR.
    Clin Cancer Res; 2009 Apr 15; 15(8):2756-66. PubMed ID: 19318495
    [Abstract] [Full Text] [Related]

  • 13. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
    Søndergaard H, Coquet JM, Uldrich AP, McLaughlin N, Godfrey DI, Sivakumar PV, Skak K, Smyth MJ.
    J Immunol; 2009 Dec 01; 183(11):7326-36. PubMed ID: 19915059
    [Abstract] [Full Text] [Related]

  • 14. Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma.
    Dasgupta S, Bhattacharya-Chatterjee M, O'Malley BW, Chatterjee SK.
    Mol Ther; 2006 Jan 01; 13(1):183-93. PubMed ID: 16125469
    [Abstract] [Full Text] [Related]

  • 15. Interferon-gamma produced by interleukin-12-activated tumor infiltrating CD8+T cells directly induces apoptosis of mouse hepatocellular carcinoma.
    Komita H, Homma S, Saotome H, Zeniya M, Ohno T, Toda G.
    J Hepatol; 2006 Nov 01; 45(5):662-72. PubMed ID: 16935390
    [Abstract] [Full Text] [Related]

  • 16. Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma.
    Kato Y, Yoshimura K, Shin T, Verheul H, Hammers H, Sanni TB, Salumbides BC, Van Erp K, Schulick R, Pili R.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4538-46. PubMed ID: 17671140
    [Abstract] [Full Text] [Related]

  • 17. Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells.
    Inoue M, Plautz GE, Shu S.
    Cancer Res; 1996 Oct 15; 56(20):4702-8. PubMed ID: 8840987
    [Abstract] [Full Text] [Related]

  • 18. Divergent effects of 4-1BB antibodies on antitumor immunity and on tumor-reactive T-cell generation.
    Kim JA, Averbook BJ, Chambers K, Rothchild K, Kjaergaard J, Papay R, Shu S.
    Cancer Res; 2001 Mar 01; 61(5):2031-7. PubMed ID: 11280763
    [Abstract] [Full Text] [Related]

  • 19. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
    Miyahara R, Banerjee S, Kawano K, Efferson C, Tsuda N, Miyahara Y, Ioannides CG, Chada S, Ramesh R.
    Cancer Gene Ther; 2006 Aug 01; 13(8):753-61. PubMed ID: 16543916
    [Abstract] [Full Text] [Related]

  • 20. In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer.
    Nagai H, Horikawa T, Hara I, Fukunaga A, Oniki S, Oka M, Nishigori C, Ichihashi M.
    Exp Dermatol; 2004 Oct 01; 13(10):613-20. PubMed ID: 15447721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.